Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.
The experts
Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Dr Teresa Amaral, Tübingen University, Tübingen, Germany
This touchPODCAST is for healthcare professionals outside of the UK…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.